Valcrete PMS Logo

Valcreate Lifesciences and Specialty Opportunities PMS Strategy focuses on identifying companies that benefit from structural shifts in the economy, aiming for long-term wealth creation.

The Valcreate Lifesciences and Specialty Opportunities PMS Investment Approach is based on investing in businesses moving from unorganized to organized sectors or gaining market leadership.

It falls under the Thematic investment category, offering diversified exposure. As of now, the strategy has a total AUM of Rs.18.16 Cr.

Over the last 1 year, it delivered a strong return of 14.23%, outperforming many peers. Its performance is benchmarked against the S&P BSE 500 TRI, ensuring broad market comparison.

Valcreate Lifesciences and Specialty Opportunities PMS Strategy or Investment Approach - PMS Details

Strategy Name

Lifesciences and Specialty Opportunities

Start Date

10 February 2023

Category

Thematic

Benchmark

S&P BSE 500 TRI

AUM (Rs.)

Rs.18.16 Cr.

Min. Investment

Rs.50 Lakhs

Fund Manager

Mr. Rajesh Pherwani

1 Yr. Return

14.23%

3 Yr. Return

19.40%

5 Yr. Return

NA

Valcreate Lifesciences and Specialty Opportunities Portfolio Management Strategy - Portfolio Characteristics

No. of Stocks

13

Top 5 Stocks%

Not Disclosed

Top 5 Sectors%

Not Disclosed

Portfolio Age

3 Yrs, 4 Months

SIP

NA

STP

NA

Average Market Cap

58982

Valcreate Lifesciences and Specialty Opportunities PMS Strategy - Cost or Charges

Fixed Fees

2.5% of Fund Value

Variable AMC

1.5% of Fund Value

Variable Profit Sharing

20% (if above 10% profit)

Exit Load 1st Year

0.00%

Exit Load 2nd Year

0.00%

Exit Load 3rd Year

0.00%

Valcreate Lifesciences and Specialty Opportunities PMS Investment Approach - Portfolio Composition

Large Cap

21.38%

Mid Cap

16.64%

Small Cap

59.80%

Cash & Equivalent

2.18%

Check out Business Opportunities with Similar Brands

Valcreate Lifesciences and Specialty Opportunities Portfolio Strategy - Top 5 Sectors

Healthcare

43.93%

Agrochemicals

37.85%

Specialty Chemicals

16.04%

Customer ratings and reviews of Valcreate Lifesciences and Specialty Opportunities PMS Strategy

Double your Investment in 3 YearsInvest in PMS